FREDERICK, MD–(Marketwired – Jun 30, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ) www.bielcorp.com, is pleased to announce that Sree Koneru, Ph. D., VP of Product Development, will speak about the new science and technology behind chronic pain relief at the 2017 UK Pharmacy Forward Annual Conference. This meeting brings together independent and small-chain pharmacists for a one-day … Continue Reading
Author Archives
ianwar@bielcorp.com
BioElectronics Announces Health Economics Study
FREDERICK, MD–(Marketwired – Jun 29, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to announce the completion of a health economics study using its nonprescription drug-free ActiPatch® Musculoskeletal Pain Therapy for chronic pain. The goal was to investigate how using ActiPatch as a pain therapy would affect overall healthcare costs in the UK. The study involved … Continue Reading
BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)
FREDERICK, MD–(Marketwired – May 30, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating “prevention of migraine” using ActiPatch therapy. Migraine is a debilitating condition that affects more than 36 million Americans, accounting for nearly $36 billion in direct and indirect costs every year in the US alone … Continue Reading
BioElectronics Expands into Tesco in the UK Market
FREDERICK, MD–(Marketwired – May 17, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is the maker of advanced, drug-free, pain management medical devices. The Company is pleased to announce that Tesco has placed their initial order for BioElectronics’ ActiPatch® Musculoskeletal Pain Therapy devices. “We are looking forward to collaborating with this innovative retailer,” said Christopher Russell, VP of … Continue Reading
BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis
BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis FREDERICK, MD–(Marketwired – Apr 20, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, over-the-counter pain management devices. The company manufactures and markets its flagship product, ActiPatch® Chronic Musculoskeletal Pain Therapy as a drug-free, wearable … Continue Reading
BioElectronics’ ActiPatch Exhibits At Australia’s Major Pharmaceutical Event
FREDERICK, MD–(Marketwired – Mar 13, 2017) – BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced noninvasive bioelectronic pain management medical devices, is pleased to announce that its devices are being featured at the Australian Pharmacy Professional Conference and Trade Exhibition. The conference and trade exhibition is the largest pharmaceutical event in Australia with 232 exhibitors … Continue Reading
BioElectronics Announces ActiPatch® Available on Amazon
FREDERICK, MD, USA, BioElectronics Corporation (OTC Pink: BIEL), February 9, 2017 8:30 AM, the maker of advanced pain management medical devices, today announced that ActiPatch® Musculoskeletal Pain Therapy device is now available on the US Amazon.com. ActiPatch is the leading nonprescription pain therapy in the United Kingdom with over 300 reviews that rate the device … Continue Reading
BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy
FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the … Continue Reading